Keywords: amgen, 4th-qtr, income, up, 833m, short, analysts
Amgen's 4th-qtr income up 1.1% to $833M, short of analysts predictions
Article | 05 February 2007
USA-based biotechnology giant Amgen's net income for the fourth quarter crept up 1.1% to $833.0 million, or $0.71 per share, from the $824.0 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
